Literature DB >> 12440196

Change in antimicrobial resistance pattern of Salmonella Typhi in central India.

Chhaya Chande1, Sunanda Shrikhande, Sadhana Kapale, Seema Agrawal, R P Fule.   

Abstract

BACKGROUND &
OBJECTIVES: Multidrug resistant Salmonella Typhi infections have been reported worldwide in the last decade. In a study from central India in 1991 multidrug resistant S. Typhi were reported to account for 91 per cent of patients of enteric fever. The present study was planned to study the antimicrobial susceptibility pattern, phage types and biotypes of strains of S. Typhi prevalent in this region.
METHODS: A total of 54 isolates of Salmonella were recovered from 1468 blood samples of patients suspected to have enteric fever and admitted in the Government Medical College and Hospital, Nagpur. Antimicrobial susceptibility pattern of these isolates was studied by disc diffusion test. Phage typing and biotyping of the first 33 strains was done at the National Salmonella Phage Typing Center, New Delhi. Minimum inhibitory concentration of chloramphenicol was determined by agar dilution method.
RESULTS: Of 54 isolates of Salmonella, 51(94%) were S. Typhi and 3 (6%) were S. paratyphi A serotype. Of the 30 isolates of S. Typhi subjected to phage typing, two phage types E1 23 (77%) and A 7 (23%) were found to be prevalent in this region. Multidrug resistance was observed in 12 (22%) strains of S. Typhi. Thirty five (68%) strains were sensitive to chloramphenicol, ampicillin, gentamicin, cotrimoxazole, cefotaxime and ciprofloxacin. Resistance to two antibiotics was observed in 4 (8%) strains. Cefotaxime resistance was observed in one isolate and gentamycin resistance in two, while none of the isolates was found to be ciprofloxacin resistant. INTERPRETATION &
CONCLUSION: Multidrug resistance in S. Typhi has decreased from that reported in 1991 though there is a still a small percentage of strains which continue to be multidrug resistant.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12440196

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  8 in total

1.  Resistance pattern of ciprofloxacin against different pathogens.

Authors:  Syeda Q Ali; Ale Zehra; Baquar S Naqvi; Shahjahan Shah; Rabia Bushra
Journal:  Oman Med J       Date:  2010-10

2.  Antibiogram Profile of Salmonella enterica Serovar Typhi in India - A Two Year Study.

Authors:  Yashwant Kumar; Anshu Sharma; Kavaratty Raju Mani
Journal:  Trop Life Sci Res       Date:  2013-08

3.  Occurrence & antibiogram of Salmonella Typhi & S. Paratyphi A isolated from Rourkela, Orissa.

Authors:  S S Bhattacharya; Usha Das; B K Choudhury
Journal:  Indian J Med Res       Date:  2011-04       Impact factor: 2.375

4.  Pefloxacin as a surrogate marker for quinolone susceptibility in Salmonella enterica serovars Typhi & Paratyphi A in India.

Authors:  Priyanka Sharma; Sushila Dahiya; Bhavana Kumari; Veeraraghavan Balaji; Seema Sood; Bimal Kumar Das; Arti Kapil
Journal:  Indian J Med Res       Date:  2017-05       Impact factor: 2.375

5.  Estimating the burden of enteric fever in Chhattisgarh: A single-center study on culture-positive cases from a newly built tertiary care hospital.

Authors:  Debabrata Dash; Padma Das; Anudita Bhargava; Ujjwala Nitin Gaikwad; Sanjay Singh Negi; Archana Wankhede
Journal:  J Lab Physicians       Date:  2019 Jul-Sep

6.  Sensitivity Pattern Of Salmonella typhi And Paratyphi A Isolates To Chloramphenicol And Other Anti-Typhoid Drugs: An In Vitro Study.

Authors:  Niranjan Patil; Prashant Mule
Journal:  Infect Drug Resist       Date:  2019-10-14       Impact factor: 4.003

7.  Diversity and evolution of the small multidrug resistance protein family.

Authors:  Denice C Bay; Raymond J Turner
Journal:  BMC Evol Biol       Date:  2009-06-23       Impact factor: 3.260

8.  Antimicrobial susceptibility patterns of Salmonella enterica serotype typhi in eastern Nepal.

Authors:  Basudha Khanal; Sanjib Kumar Sharma; Shyamal Kumar Bhattacharya; Narayan Raj Bhattarai; Monorama Deb; Reba Kanungo
Journal:  J Health Popul Nutr       Date:  2007-03       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.